Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
3M | MMM | Apr 21, 2025 | 126.09 | -3.16 |
4D Molecular Therapeutics | FDMT | Apr 21, 2025 | 3.08 | +0.65 |
51Talk Online Education Group ADR | COE | Apr 21, 2025 | 15.38 | +4.41 |
5E Advanced Materials | FEAM | Apr 21, 2025 | 4.32 | +1.41 |
60 Degrees Pharmaceuticals | SXTP | Apr 21, 2025 | 3.16 | 0.00 |
7-10 Yr Trsy Bear 3X Direxion | TYO | Apr 21, 2025 | 14.07 | +1.80 |
7-10 Yr Trsy Bull 3X Direxion | TYD | Apr 21, 2025 | 24.44 | -1.61 |
7-10 Yr Trsy Ishares | IEF | Apr 21, 2025 | 94.17 | -0.54 |
89bio | ETNB | Apr 21, 2025 | 6.27 | +3.47 |
8x8 | EGHT | Apr 21, 2025 | 1.64 | +3.80 |
908 Devices | MASS | Apr 21, 2025 | 4.80 | +0.95 |
9F ADR | JFU | Apr 21, 2025 | 1.02 | -3.77 |
A-Mark Precious Metals | AMRK | Apr 21, 2025 | 24.09 | +2.21 |
a.k.a Brands | AKA | Apr 21, 2025 | 7.87 | -9.95 |
A.O Smith | AOS | Apr 21, 2025 | 61.71 | -2.26 |
A10 Networks | ATEN | Apr 21, 2025 | 15.30 | -2.86 |
A2Z Cust2Mate Solutions | AZ | Apr 21, 2025 | 7.83 | +1.23 |
AA Mission Acquisition | AAM | Apr 21, 2025 | 10.27 | 0.00 |
AAA - A Rated Corporate Bond Ishares | QLTA | Apr 21, 2025 | 46.56 | -0.79 |
Aadi Bioscience | AADI | Apr 21, 2025 | 2.05 | 0.00 |
AAON | AAON | Apr 21, 2025 | 77.92 | -5.51 |
AAR | AIR | Apr 21, 2025 | 51.02 | -3.39 |
Aardvark Therapeutics | AARD | Apr 21, 2025 | 7.12 | 0.00 |
Abacus Global Management | ABL | Apr 21, 2025 | 8.06 | -1.10 |
Abbott Laboratories | ABT | Apr 21, 2025 | 129.89 | -0.83 |
AbbVie | ABBV | Apr 21, 2025 | 170.16 | -1.64 |
AbCellera Biologics | ABCL | Apr 21, 2025 | 2.45 | +1.24 |
Abeona Therapeutics | ABEO | Apr 21, 2025 | 4.92 | +1.65 |
Abercrombie & Fitch | ANF | Apr 21, 2025 | 72.77 | -0.29 |
Aberdeen Asia-Pacificome Fund | FAX | Apr 21, 2025 | 15.00 | -0.07 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.